PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034437

TXM-CB3

Evidence text

Paper-level observation

Fig. 5D-E: cumulative seizure burden further confirmed that CB3-treated animals experienced fewer seizures than control animals across the study period.
textConfidence: medium

Assay observation

Activity
Other
Subtype
Not reported by source
Measure
other
Comparator
=
Raw observation
fewer seizures than control animals across the study period
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.